News

The federal 340B drug pricing program is failing to meet the needs of the vulnerable patients the program was intended to serve, while raising health care costs for employers and families, according to a new white paper.

36% of employees feel hopeless, anxious or frustrated about their financial situation.

After turning over more than 1,300 documents to the Federal Trade Commission, the fast food giant is turning its attention to subpoenas from pharmacy benefit managers the agency accuses of artificially inflating insulin prices.

The full billed price for a double lung transplant for a patient under 65 increased 81% between 2020 and this year, to $2.3 million, the firm estimates.

The company put out a statement on Friday rejecting the allegations, but the Wall Street Journal article caused a 7.17% drop in the price of its stock.

The cannabis industry’s premier partner in human resources and payroll solutions has launched a fully-vetted retirement plan by partnering with Vanguard, First Citizens Bank and PCSRetirement.